Teratogenic risks from exposure to illicit drugs
- PMID: 24845487
- DOI: 10.1016/j.ogc.2014.02.008
Teratogenic risks from exposure to illicit drugs
Abstract
Substance use is prevalent in the United States, especially in the reproductive age population. Even though a reduction in substance use may occur during pregnancy, some women may not alter their drug use patterns until at least pregnancy is confirmed. For these reasons, a large number of fetuses are exposed to illicit substances, including during critical stages of organogenesis. Associating illicit drug use with eventual pregnancy outcome is difficult. This article presents issues pertaining to limitations with published investigations about fetal risks and describes the most current information in humans about fetal effects from specific illicit substances.
Keywords: Addiction; Fetal effects; Illicit drug use; Pregnancy complications; Teratogenic risk.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Maternal and fetal effects from substance use.Clin Perinatol. 2007 Dec;34(4):559-71, vi. doi: 10.1016/j.clp.2007.09.001. Clin Perinatol. 2007. PMID: 18063105 Review.
-
Smoke, alcohol consumption and illicit drug use in an Italian population of pregnant women.Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):106-10. doi: 10.1016/j.ejogrb.2011.07.042. Epub 2011 Aug 9. Eur J Obstet Gynecol Reprod Biol. 2011. PMID: 21831510
-
The effects of drug abuse on pregnancy.Curr Opin Obstet Gynecol. 2007 Dec;19(6):578-85. doi: 10.1097/GCO.0b013e3282f1bf17. Curr Opin Obstet Gynecol. 2007. PMID: 18007137 Review.
-
The consequences of maternal substance abuse for the child exposed in utero.Psychosomatics. 1991 Summer;32(3):268-74. doi: 10.1016/S0033-3182(91)72064-1. Psychosomatics. 1991. PMID: 1882017 Review.
-
Adverse consequences of prenatal illicit drug exposure.Curr Opin Obstet Gynecol. 1996 Dec;8(6):403-11. Curr Opin Obstet Gynecol. 1996. PMID: 8979011 Review.
Cited by
-
FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.Int J Gynaecol Obstet. 2021 Mar;152 Suppl 1(Suppl 1):3-57. doi: 10.1002/ijgo.13522. Int J Gynaecol Obstet. 2021. PMID: 33740264 Free PMC article.
-
Assessing the relationship between neonatal abstinence syndrome and birth defects in Delaware.Birth Defects Res. 2021 Jan 15;113(2):144-151. doi: 10.1002/bdr2.1811. Epub 2020 Sep 30. Birth Defects Res. 2021. PMID: 32996723 Free PMC article.
-
Immunological Role of the Maternal Uterine Microbiome in Pregnancy: Pregnancies Pathologies and Alterated Microbiota.Front Immunol. 2020 Jan 8;10:2823. doi: 10.3389/fimmu.2019.02823. eCollection 2019. Front Immunol. 2020. PMID: 31969875 Free PMC article. Review.
-
Prevalence of self-reported mental disorders in pregnancy and associations with adverse neonatal outcomes: a population-based cross-sectional study.BMC Pregnancy Childbirth. 2019 Nov 8;19(1):412. doi: 10.1186/s12884-019-2572-4. BMC Pregnancy Childbirth. 2019. PMID: 31703644 Free PMC article.
-
Women and substance use disorders in low- and middle-income countries: A call for advancing research equity in prevention and treatment.Subst Abus. 2020;41(1):6-10. doi: 10.1080/08897077.2019.1680481. Epub 2019 Nov 7. Subst Abus. 2020. PMID: 31697188 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical